Ipsen SA annual revenue
2020
2021
2022
2023
2024
2025
Ipsen SA Revenue Growth & History (IPN)
Ipsen SA reported €3.93B in revenue for fiscal 2025, an increase of 9.92% from the previous fiscal year.
View full Ipsen SA company overviewIpsen SA annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €3.93B | €354.7M | +9.92% |
| 2024 | 2024-12-31 | €3.57B | €268.1M | +8.11% |
| 2023 | 2023-12-31 | €3.31B | €150.0M | +4.75% |
| 2022 | 2022-12-31 | €3.16B | €157.3M | +5.24% |
| 2021 | 2021-12-31 | €3.00B | €312.9M | +11.65% |
| 2020 | 2020-12-31 | €2.69B | — | — |
Ipsen SA revenue growth trends
Over the last five reported fiscal years, revenue grew from €2.69B to €3.93B, a compound annual growth rate of 7.90%.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Ipsen SA source filings ↗Community posts
Ipsen lifts annual growth and margin forecasts after strong drug sales
Ipsen ($IPN) raised its 2026 sales-growth target to approximately 23% at constant exchange rates, from more than 20%, and its core operating-margin forecast to around 39%, from above 37%. Third-quarter revenue reached €1.17 billion, increas ...
